6 news items
Why Sharps Technology Stock Is Up
STSS
13 Jun 24
.
The Details:
Sharps said the purchase order represents the first 12 months of syringe purchase commitments of an enhanced asset
Sharps Technology's SC Facility Asset Purchase And Syringe Sales Agreement Will Pave The Way To Begin Producing Prefillable Specialty Copolymer Syringes In The U.S.
STSS
31 May 24
for the first five years of operation.Sharps is negotiating additional pharma-segment purchase commitments for orders over the next three
Sharps Technology's SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
STSS
31 May 24
. Sharps is negotiating additional pharma-segment purchase commitments for orders over the next three years, with shipments expected to begin by Q2
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
STSS
30 May 24
commitments for orders over the next 3 years, with shipments expected to begin by Q2 of 2025 NEW YORK and WEST COLUMBIA, S.C., May 30, 2024
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
STSS
28 May 24
market, and plan to bolster our manufacturing capabilities with the addition of a US facility in the near term. Our commitment to quality and safety
hshm1zn9pzys8bh x851iv5nwsg5672yyrxss
STSS
28 May 24
a five-year Purchase Agreement with Nephron SC and Nephron Sterile, under which Nephron commits to exclusively use the company as its pre-filled
- Prev
- 1
- Next